Steward Partners Investment Advisory’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-200
Closed -$5.12K 3403
2023
Q2
$5.12K Buy
+200
New +$4.74K ﹤0.01% 2779
2021
Q2
Sell
-500
Closed -$21.9K 7193
2021
Q1
$21.9K Buy
+500
New +$22.7K ﹤0.01% 2429
2020
Q2
Sell
-70
Closed -$1K 2687
2020
Q1
$1K Hold
70
﹤0.01% 2375
2019
Q4
$2K Sell
70
-75
-52% -$2.54K ﹤0.01% 2425
2019
Q3
$4K Sell
145
-236
-62% -$8.07K ﹤0.01% 2290
2019
Q2
$13K Buy
+381
New +$12.8K ﹤0.01% 1870
2018
Q4
Sell
-381
Closed -$15K 1231
2018
Q3
$15K Hold
381
﹤0.01% 1689
2018
Q2
$13K Buy
+381
New +$13.3K ﹤0.01% 1646

Other funds holding FFTY

Steward Partners Investment Advisory's FFTY Position: Q3 2023 in Review

Steward Partners Investment Advisory sold out of CapForce IBD 50 ETF (FFTY) in Q3 2023, closing a stake of 200 shares — an estimated $5.12K sold.

Steward Partners Investment Advisory first reported a position in FFTY in Q2 2018 and held it in 8 quarters. The position peaked at $21.9K in Q1 2021. 40 funds tracked by Wall St. Rank hold FFTY as of Q3 2023.

  • Steward Partners Investment Advisory reported no remaining CapForce IBD 50 ETF position as of Q3 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 200 CapForce IBD 50 ETF shares in Q3 2023, an estimated $5.12K.
  • Steward Partners Investment Advisory first reported a position in CapForce IBD 50 ETF in Q2 2018 and held it in 8 quarters.
  • Steward Partners Investment Advisory's CapForce IBD 50 ETF position peaked at $21.9K in Q1 2021.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2023, filed 13 Nov 2023.